Introduction
We have previously reported the deficiency of a normal sialoglycoprotein with a relative molecular mass of 115 kD (designated gpL-1 15) in the lymphocytes of patients with WiskottAldrich syndrome (WAS)' and other X-linked T lymphocyte immunodeficiencies (1) (2) (3) . The production ofa monoclonal antibody (designated L-10) to gpL-1 15 has permitted us to evaluate the molecular heterogeneity of the lymphocyte gpL-115 abnormalities (2) . Normal lymphocyte gpL-I 15 is stable in vitro whereas gpL-1 15 from lymphocytes of immunodeficient patients undergoes partial degradation. The Receivedfor publication 14 July 1986.
1. Abbreviations used in this paper: WAS, Wiskott-Aldrich syndrome.
the variable presence ofeczema and/or immunodeficiency. The patients with T lymphocyte immunodeficiency resulting from the deficiency of gpL-1 15 have been previously described (3) .
Purification and separation of lymphocytes. Peripheral blood was collected in either preservative-free heparin (100 U/ml) or acid-citratedextrose (National Institutes of Health, Formula A, 0.17 ml/ml). Blood specimens were processed either immediately (fresh) or after overnight air shipment or storage at room temperature (overnight). Mononuclear cells were isolated on Ficoll-Hypaque gradients. After collecting the mononuclear cells, they were washed in Hanks' balanced salt solution, resuspended in Hanks' with 5% inactivated fetal bovine serum (Irvine Scientific, Irvine, CA), and incubated at 5 X 106 cells/ml in 100-ml tissue culture dishes (Falcon 1029, Falcon Labware, Cockeysville, MD) for 1 h at 370C in a 5% CO2 incubator. The nonadherent cells (lymphocytes) were collected. In some experiments whole blood samples were centrifuged, and the plasma was removed. The patients' plasma was added to the erythrocytes-leukocytes of normal individuals, and the plasma from normal individuals was added to erythrocytes-leukocytes from the patients. After resuspension, the samples were maintained at room temperature overnight before leukocyte separation. T and non-T lymphocytes were prepared by bulk erythrocyte rosette formation. Lymphocytes were incubated at 4VC for 2 h with neuraminidase-treated sheep red blood cells. The lymphocytes were centrifuged at 150 g for 10 min, gently resuspended, and separated on a Ficoll-Hypaque gradient. Interphase cells (non-T lymphocytes) contained < 10% erythrocyte rosette-forming cells, whereas the pelleted lymphocytes after lysis with 0.87% Tris-ammonium chloride contained > 90% erythrocyte rosette-forming cells (T lymphocytes). Thymocytes were obtained from thymus removed as a routine component of open heart surgery. Granulocytes were obtained by the dextran sedimentation of peripheral blood leukocytes. The leukocyte-rich supernatant was separated on Ficoll-Hypaque gradients; the pelleted cells contained > 80% granulocytes. Cell lines (CEM and U937) were routinely grown in RPMI 1640 with 10% heat inactivated fetal bovine serum with 1 X 10-2 M glutamine and penicillin/streptomicin added.
Sialidase treatment. Lymphocytes at 1 X 107/ml were treated with Vibrio cholerae sialidase as previously described (2) .
Cell lysis. Cells were routinely lysed at a concentration of 24 X 106 cells/ml except for thymocytes, which were lysed at 48 X 106/ml. The lysis buffer contained of 0.5% NP-40 in 10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM phenylmethylsulfunyl fluoride, and 3 mM iodoacetamide. The lysates were filtered through 0.2-Am Millipore filters (Millipore Corp., Bedford, MA) and stored at -70°C until use.
Monoclonal antibodies. L-10 is a murine IgG2a monoclonal antibody which reacts with both the sialo and asialo forms of gpL-1 15. L-2 is an IgE monoclonal antibody which reacts with only the sialo form of gpL-115. The production of the monoclonal antibodies has been previously described (2) . The (4) . After the completion of the electrophoretic run, the proteins were transferred from the polyacrylamide gel to a nitrocellulose membrane by overnight electroblotting. The transfer buffer was 25 mM Tris-192 mM glycine, pH 8.3, diluted 4:1 with methanol. After transfer, the ni-trocellulose membranes were blocked for 1 h with gelatin buffer (3% gelatin in 20 mM Tris, 500 mM NaCl, pH 7.5) and then incubated for 3 h with a 1:10 dilution of L-l0 or L-2 tissue culture supernatant or control mouse ascites. After washing, the L-l0-reacted nitrocellulose membranes were incubated with a 1:2,000 dilution of peroxidase-labeled goat anti-mouse IgG (Bio-Rad Laboratories, Richmond, CA). With L-2, the nitrocellulose membranes were incubated with a 1:100 dilution of rabbit anti-mouse IgE for 1 h, followed by washing and incubation with a 1:1,000 dilution of peroxidase-labeled goat anti-rabbit IgG (BioRad Laboratories). After washing, the nitrocellulose membranes were developed with 4-chloro-napthol (Bio-Rad Laboratories), and the immunoblots were photographed. M, were calculated from high molecular weight marker standards (Bethesda Research Laboratories, Gaithersburg, MD).
Results
Antigenic reactivity ofL-10 and L-2. L-I0 and L-2 monoclonal antibodies were developed by the immunization ofBALB/c mice with a T lymphoblast cell line, CEM. L-l0 reacts with both the sialo and asialo forms of gpL-1 15, whereas L-2 only reacts with the fully sialated form by immunofluorescence and immunoprecipitation (2) . After the gel electrophoresis of cell lysates and their transfer to nitrocellulose membranes, L-10 reacts predominantly with a single molecular species from all lymphoid cells (peripheral blood lymphocytes, T lymphoblast cell lines, thymocytes, and B lymphoblast cell lines) and with multiple molecular species from cells of myeloid origin (granulocytes, monocytes, and U937) (Fig. 1 Fig. 4 . A total absence of gpL-l 15 was detected in some patients with the appearance of L-10-reactive bands with higher or lower Mr (Fig. 4 , lanes A, E, and K). Lymphocytes from other patients had detectable gpL-1 5 with the presence of additional L-10-reactive bands with either higher or lower Mr. In total, 17 immunodeficient patients were analyzed (Table I) . Nine patients had a pattern characterized by L-10-reactive glycoprotein with Mr of both 95 and 115 kD ( To determine the basis for the molecular heterogeneity in gpL-l 15 of patients, lymphocytes taken from patients were isolated on both the day ofcollection and after overnight incubation. When the samples were analyzed simultaneously, no abnormality in gpL-1 15 of patients was detected in the fresh lymphocytes whereas multiple L-lO-reactive glycoproteins were detected after overnight incubation. To determine whether the degradation ofgpL-l 15 in plasma of patients was due to the presence ofenzymes that might degrade lymphocyte gpL-l 15, the samples from patients were centrifuged, the plasma was removed, and plasma from normal individuals was added. Conversely, the plasma from the patients was added to erythrocytes-leukocytes from normal individuals. After overnight incubation at room temperature, the leukocytes from both patients and normal individuals were isolated as usual. Degradation of the gpL-l 15 from patients occurred regardless of whether the lymphocytes of patients were incubated in plasma of patients or normal individuals (Fig. 5, 
lanes B, C and E, F). No degradation of gpL-
115 occurred when lymphocytes from normal donors were incubated with plasma from patients (Fig. 5, lanes I and J) . These results indicate that the degradation seen in gpL-1 15 from patients was not due to the presence ofabnormal plasma enzymatic activity. Equivalent degradation of gpL-l 15 from patients occurred when freshly isolated lymphocytes from patients were incubated overnight in heat-inactivated fetal bovine serum (data not shown).
gpL-11S analysis of lymphocyte subsets. To determine whether the observed molecular heterogeneity in gpL-l 15 was iodinated bands (Mr 95 and 135 kD) not seen in lymphocytes from normal donors; however, the antigenic relationship of the additional bands to gpL-115 was not clear. The production of monoclonal antibodies to gpL-1 15 has permitted an examination of the molecular heterogeneity of the gpL-1 15 abnormalities in lymphocytes from immunodeficient patients. Immunoblotting has revealed that the patients with WAS and other T lymphocyte immunodeficiencies are heterogeneous, exhibiting a series ofgpL-115 degradation products. The heterogeneity in gpL-l 15 degradation suggests that WAS is not due to a single primary defect but may represent a class of deficiencies, all of which involve abnormalities of lymphocyte gpL-l 15. The heterogeneity ofgpL-115 deficiency may explain the clinical heterogeneity seen in WAS patients and other patients with X-linked T lymphocyte immunodeficiencies, who lack platelet abnormalities (3). L-10 and L-2 antibodies react with all nucleated cells oflymphohematopoietic origin. Mature T and B lymphocytes have a single glycoprotein with an Mr of 115-120 kD. Analysis of thymocytes and CEM, which has a thymocyte-like phenotype, with L-10 reveals an additional band with a higher M, which may be due to the undersialation of some gpL-l 15 on immature T lymphocytes (5) . After the treatment of peripheral blood lymphocytes or lymphoid cell lines with sialidase, L-10 detects a single moiety with an M, of 150 kD, whereas L-2 displays no reactivity in that L-2 reacts with only the sialated form of gpL-115. The transfer of the desialated form of gpL-1 5 to nitrocellulose membranes is not so quantitative as the sialated form even though both are equally immunoprecipitated by L-10 (2). Analysis of myeloid cells reveals L-10-and L-2-reactive bands with higher Mr than that of lymphoid cells. The multiple bands are not due to the proteolysis of gpL-I 15 because identical patterns were obtained when U937 and granulocyte membranes were prepared by sonication and isolated on a sucrose cushion instead of by NP-40 lysis.
Normal lymphocyte gpL-1 15 is stable in vitro with little degradation and a low rate of turnover, < 10% per day (Parkman, R., unpublished data). Normal peripheral blood lymphocytes cultured for 4 (6) . Further allelic exclusion studies have shown a lack of B lymphocyte exclusion in some obligate heterozygotes, suggesting that the B lymphocytes are not involved in all cases of WAS (7) .
The present results conflict with our original report in which glycoprotein abnormalities were noted on gels from freshly isolated WAS lymphocytes after surface iodination. Although the lactoperoxidase method was used, it is possible that the observed abnormalities were due to oxidative degradation produced by the lactoperoxidase. The lactoperoxidase may induce degradative changes similar to those observed after overnight incubation in that the additional iodinated bands previously noted had M, of 95 and 135 kD.
Axelsson et al. (8, 9) have described a chicken antibody to a lymphocyte glycoprotein (LSGP) that has many similarities to gpL-1 15 (Mr, cellular specificity, etc.). The antibody was raised to the asialo form of the LSGP, and its reactivity is reciprocal to the reactivity of L-2 in that the LSGP antibody reacts with only the asialoglycoprotein, whereas L-2 reacts only with the sialated form of gpL- 1 
